You are here



11 Nov 2010: NorDiag ASA invites to a presentation of the Q3 results on November 18, 2010 at 8:30am at Thon Hotel Vika Atrium, Munkedamsveien 45, Oslo.

Please confirm your participation to, or by calling +47 22 02 65 91. Shareholders who wish to receive the quarterly report by mail are requested to send an email regarding this to the same email address.

Representatives from the Company will be CEO Mårten Wigstøl and CFO Tone Kvåle.

The report and the presentation will be published on NorDiag's homepage

CFO Tone Kvåle, phone: +47 915 19 576.

About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and tests) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The company has offices and laboratories in Stockholm, Sweden, in West Chester (PA), USA and in Vienna, Austria. The group has today 38,4 man- labour years. NorDiag is listed on Oslo Stock Exchange with ticker NORD.

For further information

Read the notice in Norwegian here